Sinoway Industrial Co., Ltd.

Tenofovir Alafenamide Fumarate (TAF) 1392275-56-7 Tenofovir Alafenamide Fumarate (TAF) 1392275-56-7

Tenofovir Alafenamide Fumarate (TAF) 1392275-56-7
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

1.Basic information of Tenofovir Alafenamide Fumarate 1392275-56-7:

Product name

Tenofovir Alafenamide Fumarate

Alias

TAF

CAS No.:

1392275-56-7

EINECS No.:

805-448-8

Appearance

White powder

MF:

2(C21H29N6O5P).C4H4O4

Grade

Enterprise standard

Assay

98.0~102.0%

Packaging details

25kg/drum, or as the requirement


2.Usage of Tenofovir Alafenamide Fumarate 1392275-56-7 :

Tenofovir Alafenamide Fumarate (TAF) is the only hepatitis B drug approved globally in the past 10 years and should be considered the best hepatitis B drug so far. Tenofovir Alafenamide Fumarate (trade name Vemlidy) is an innovative, targeted, Tenofovir (tenofovir) prodrug, and the former product of tenofovir disoproxil fumarate (commodity) Compared to Viread (TDF), less than one-tenth of the dose is required to achieve similar antiviral effects.

Clinical data show that the newly approved Tenofovir Alafenamide Fumarate (TAF) has greater plasma stability and is more effective in delivering tenofovir to hepatocytes, since the dose can be lower. Decreased the concentration of tenofovir in the blood, therefore, compared with tenofovir disoproxil fumarate, tenofovir alafluramine can more effectively improve the patient's kidney and bone safety parameters.

3.COA of Tenofovir Alafenamide Fumarate 1392275-56-7 :


Tenofovir Alafenamide Fumarate (TAF) 1392275-56-7





  • Febuxostat 144060-53-7
    Basic information of FebuxostatNameFebuxostatAlias2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic AcidCAS Number144060-53-7Molecular FormulaC16H16N2O3SMolecular Weight316.37Quality... Febuxostat 144060-53-7
  • Chlortetracycline 57-62-5
    Basic information of Chlorotetracycline :NameChlorotetracyclineAliasacronize ;aureocina ;aureomycina-377 ;aureomykoin ;biomitsin ;chlortetracycline ;chrysomykine ;duomycinCAS NO.57-62-5Molecular Form... Chlortetracycline 57-62-5
  • Betamethasone Valerate 2152-44-5
    Basic information of Betamethasone Valerate :NameBetamethasone ValerateAliaspregna-1,4-diene-3,20-dione,9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopenty ;9-fluoro-11beta,17,21-trihydroxy-16beta-meth... Betamethasone Valerate 2152-44-5
  • Iron Sucrose 8047-67-4
    Basic informationOther Names: Iron(III) saccharateCAS No.: 8047-67-4 Appearance:Brown-dark liquid Document: GMP/DMF/Technical support.Appearance:Brown-dark liquid UsageAnti-anemia medicine, which ca... Iron Sucrose 8047-67-4

MORE_DETAIL Tenofovir Alafenamide Fumarate (TAF) 1392275-56-7

1.Basic information of Tenofovir Alafenamide Fumarate 1392275-56-7:

Product name

Tenofovir Alafenamide Fumarate

Alias

TAF

CAS No.:

1392275-56-7

EINECS No.:

805-448-8

Appearance

White powder

MF:

2(C21H29N6O5P).C4H4O4

Grade

Enterprise standard

Assay

98.0~102.0%

Packaging details

25kg/drum, or as the requirement


2.Usage of Tenofovir Alafenamide Fumarate 1392275-56-7 :

Tenofovir Alafenamide Fumarate (TAF) is the only hepatitis B drug approved globally in the past 10 years and should be considered the best hepatitis B drug so far. Tenofovir Alafenamide Fumarate (trade name Vemlidy) is an innovative, targeted, Tenofovir (tenofovir) prodrug, and the former product of tenofovir disoproxil fumarate (commodity) Compared to Viread (TDF), less than one-tenth of the dose is required to achieve similar antiviral effects.

Clinical data show that the newly approved Tenofovir Alafenamide Fumarate (TAF) has greater plasma stability and is more effective in delivering tenofovir to hepatocytes, since the dose can be lower. Decreased the concentration of tenofovir in the blood, therefore, compared with tenofovir disoproxil fumarate, tenofovir alafluramine can more effectively improve the patient's kidney and bone safety parameters.

3.COA of Tenofovir Alafenamide Fumarate 1392275-56-7 :


Tenofovir Alafenamide Fumarate (TAF) 1392275-56-7




Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//